Understanding Multiple Sclerosis and How Medical Marijuana Can Help Manage Symptoms
Imagine waking up one day and feeling a strange numbness in your limbs, a fatigue so intense that even lifting a coffee cup feels like a workout, or sudden spasms in your muscles that make everyday tasks painful. For more than 2.8 million people worldwide, this isn’t just a bad day—it’s a daily reality. These are common symptoms of Multiple Sclerosis (MS), a chronic autoimmune disease that targets the central nervous system and can dramatically impact quality of life.
While traditional treatments offer some relief, they often come with side effects or limited long-term results. That’s why more patients and doctors are turning their attention to a natural alternative: medical marijuana. Backed by growing scientific research and patient success stories, cannabis is quickly becoming a promising option for managing MS symptoms like pain, muscle stiffness, fatigue, and even cognitive challenges.
In this article, we’ll explore what Multiple Sclerosis really is, how it affects the body, and why medical marijuana is emerging as a game-changing tool in symptom management—especially for those in Virginia seeking legal and effective access to cannabis care.
What Is Multiple Sclerosis?
Multiple Sclerosis (MS) is a chronic, often disabling autoimmune disease that directly affects the central nervous system (CNS), which includes the brain, spinal cord, and optic nerves. In individuals with MS, the body’s immune system mistakenly attacks myelin, the protective sheath that covers nerve fibers. This myelin damage disrupts communication between the brain and the rest of the body, causing a wide variety of physical, emotional, and cognitive symptoms.
The exact cause of MS remains unknown, but research suggests that a combination of genetic predisposition and environmental factors may trigger the disease. It typically appears between the ages of 20 and 50 and is more common in women than in men. While MS is not considered fatal for most people, it can lead to significant disability over time, especially without proper treatment and symptom management.
Types of Multiple Sclerosis
Multiple Sclerosis (MS) is not a one-size-fits-all condition. It presents in various forms, each with its own pattern of progression and symptoms. Understanding the different types of MS is crucial for both patients and healthcare providers, as it helps guide treatment plans and long-term care strategies. While all types of MS involve damage to the central nervous system, the way this damage manifests and evolves can differ greatly from person to person.
Here are the four main types of Multiple Sclerosis:
1. Relapsing-Remitting Multiple Sclerosis (RRMS)
Relapsing-Remitting MS is the most common form, affecting approximately 85% of all MS patients at the time of diagnosis. RRMS is characterized by clearly defined flare-ups or relapses, during which new symptoms appear or existing ones worsen. These relapses are followed by periods of remission, where symptoms may partially or completely disappear.
During remission, the disease does not appear to progress, although some damage to the nervous system can remain. RRMS often responds well to disease-modifying therapies (DMTs), which aim to reduce the frequency and severity of relapses.
2. Secondary Progressive Multiple Sclerosis (SPMS)
Secondary Progressive MS typically develops in individuals who initially had RRMS. Over time, many patients experience a transition from relapsing-remitting episodes to a steady progression of neurological decline, with or without relapses or remissions.
In SPMS, the inflammation seen in earlier stages is often replaced by more constant nerve damage or loss. While relapses may still occur, the focus of treatment shifts toward slowing disability progression and managing symptoms more aggressively.
3. Primary Progressive Multiple Sclerosis (PPMS)
Primary Progressive MS affects about 10–15% of people diagnosed with the disease. Unlike RRMS, PPMS is marked by a gradual worsening of neurological function from the onset, without clear relapses or remissions. Symptoms may stabilize at times but generally do not improve significantly.
PPMS tends to affect mobility and motor function early on, and it can be more resistant to traditional MS treatments. Newer therapies, such as Ocrelizumab, have shown promise in slowing the progression of this form of MS, particularly in its early stages.
4. Progressive-Relapsing Multiple Sclerosis (PRMS)
Progressive-Relapsing MS is the least common form, occurring in a small percentage of patients. PRMS involves a steady progression of disability from the start, similar to PPMS, but with occasional acute relapses or flare-ups. Unlike RRMS, there is no real remission; recovery after attacks may be incomplete, and the disease continues to advance over time.
In 2013, the classification of PRMS was revised and it is now often considered a subset of Primary Progressive MS with active disease.
Common Symptoms of Multiple Sclerosis
Multiple Sclerosis (MS) is often referred to as a “snowflake disease” because no two patients experience it in exactly the same way. The symptoms of MS can vary widely depending on the location and extent of nerve damage in the brain, spinal cord, and optic nerves. Some individuals may experience mild, intermittent issues, while others may face more severe and disabling complications. Understanding the common symptoms of MS is key to early diagnosis, symptom management, and improving quality of life.
Here’s a breakdown of the most common symptoms that people with MS often face:
1. Fatigue
Fatigue is one of the most prevalent and debilitating symptoms of MS. It affects nearly 80% of people with the condition and can significantly interfere with daily activities. MS-related fatigue is not the same as ordinary tiredness—it can come on suddenly, last for hours, and doesn't always improve with rest. This type of exhaustion is believed to be caused by nerve damage and inflammation within the central nervous system.
2. Vision Problems
Many MS patients first seek medical help due to vision disturbances. The most common issue is optic neuritis, an inflammation of the optic nerve that can cause:
Blurred or dim vision
Pain during eye movement
Partial or complete loss of sight in one eye (usually temporary)
Some people may also experience double vision or involuntary eye movements (nystagmus).
3. Tingling and Numbness
Sensory symptoms like tingling, numbness, or a “pins and needles” sensation are often among the earliest signs of MS. These can affect the face, arms, legs, and trunk. Though usually not painful, these sensations can be disturbing and may interfere with daily tasks like writing or walking.
4. Muscle Spasms and Spasticity
MS can cause muscle stiffness, cramps, and involuntary spasms, particularly in the legs. This spasticity may range from mild tightness to painful, uncontrollable muscle contractions that affect movement and balance. Left unmanaged, spasticity can lead to muscle shortening and joint deformities over time.
5. Weakness and Mobility Issues
Damage to the nerves responsible for controlling muscles can lead to muscle weakness, reduced coordination, and problems with balance and walking. Many people with MS find that their legs feel heavy or unresponsive, making everyday movements more difficult and increasing the risk of falls.
6. Bladder and Bowel Dysfunction
Up to 80% of MS patients report issues with bladder control. These may include:
Urgency (a sudden, intense need to urinate)
Frequency
Incontinence
Difficulty emptying the bladder completely
Bowel dysfunction, such as constipation or less commonly, incontinence, can also occur.
7. Cognitive Impairment
Cognitive issues are commonly reported and may include problems with:
Memory
Attention and concentration
Verbal fluency
Problem-solving and planning
These cognitive challenges can affect both professional and personal life, leading to frustration, confusion, and even depression.
8. Emotional and Mental Health Issues
Living with MS often involves navigating complex emotional changes. Depression, anxiety, and mood swings are common. In some cases, MS may lead to pseudobulbar affect, a condition characterized by sudden, uncontrollable episodes of laughing or crying that don't match the patient’s actual feelings.
9. Pain
Although once thought to be a painless condition, studies now show that up to 55% of MS patients experience chronic pain. This can result from nerve damage (neuropathic pain), muscle tightness, or joint strain caused by changes in movement patterns.
10. Sexual Dysfunction
MS can affect sexual arousal and performance due to neurological damage, fatigue, and psychological factors. Both men and women may experience a decrease in libido, difficulties with arousal, or orgasmic dysfunction.
11. Lhermitte’s Sign
This is a sudden, electric-shock-like sensation that travels down the spine and into the limbs when the neck is bent forward. It’s a classic symptom of MS and can be alarming, though it’s typically not dangerous.
12. Dizziness and Vertigo
People with MS often report feeling dizzy, lightheaded, or as if their surroundings are spinning (vertigo). This symptom is usually due to lesions in the brain stem or cerebellum.
13. Speech and Swallowing Difficulties
In advanced stages or during flare-ups, some individuals may notice slurred speech (dysarthria) or difficulty swallowing (dysphagia), both of which can impact daily communication and eating.
Over time, untreated MS may even lead to partial or complete paralysis.
What Is Clinically Isolated Syndrome (CIS)?
CIS (Clinically Isolated Syndrome) is often considered an early indicator of Multiple Sclerosis. It refers to a single episode of neurological symptoms lasting at least 24 hours, caused by inflammation or demyelination in the central nervous system.
Common CIS symptoms include:
Optic neuritis: Pain or vision loss in one eye
Lhermitte's sign: Electric shock sensation along the spine
Transverse myelitis: Muscle weakness, numbness, and bowel/bladder dysfunction
Though CIS doesn't always lead to MS, it is a major red flag, especially when accompanied by MRI findings suggestive of demyelination.
Diagnosing Multiple Sclerosis
Diagnosing MS can be challenging due to its wide range of symptoms and similarity to other neurological disorders. A neurologist typically performs several tests to confirm MS:
Blood tests to rule out other conditions
Magnetic Resonance Imaging (MRI) to detect lesions in the brain or spinal cord
Lumbar puncture (spinal tap) to analyze cerebrospinal fluid
Evoked potential tests to measure electrical activity in response to stimuli
In some cases, additional imaging or spinal fluid testing is needed to support a diagnosis.
Conventional Treatments for Multiple Sclerosis
While there is currently no cure for Multiple Sclerosis (MS), a wide range of conventional medical treatments can help manage symptoms, reduce the frequency and severity of relapses, and slow disease progression. These treatments are tailored to each patient’s specific symptoms, type of MS, and overall health status. The primary goals of conventional MS treatment are to control inflammation, manage relapses, ease symptoms, and improve the patient’s quality of life.
1. Corticosteroids for Acute Relapses
One of the most common treatments for managing MS flare-ups or relapses is corticosteroids, such as:
Oral prednisone
Intravenous methylprednisolone (IVMP)
These powerful anti-inflammatory drugs help reduce swelling in the central nervous system, shorten the duration of relapses, and improve functional recovery. However, corticosteroids are generally used short-term due to potential side effects such as weight gain, insomnia, mood changes, and increased blood sugar.
2. Plasma Exchange (Plasmapheresis)
For severe MS relapses that do not respond to steroids, plasma exchange (PLEX) may be recommended. This procedure involves removing the patient’s blood, separating out the plasma (which contains inflammatory antibodies), and replacing it with a plasma substitute before returning it to the body.
Plasmapheresis can be particularly effective for patients with aggressive forms of MS or those experiencing a sudden and debilitating neurological episode.
3. Disease-Modifying Therapies (DMTs)
Disease-modifying therapies are at the core of long-term MS treatment. These medications are designed to:
Reduce the frequency of relapses
Slow the progression of disability
Decrease the number of new brain and spinal cord lesions
Common DMTs include:
Interferon beta medications (Avonex, Rebif, Betaseron): Help modulate the immune response and reduce inflammation.
Glatiramer acetate (Copaxone): Believed to block the immune system’s attack on myelin, the protective sheath around nerve fibers.
Fingolimod (Gilenya): A daily oral medication that traps immune cells in the lymph nodes, preventing them from attacking the central nervous system.
Dimethyl fumarate (Tecfidera): An oral treatment that activates antioxidant pathways to reduce nerve damage.
Teriflunomide (Aubagio): A once-daily pill that inhibits the reproduction of immune cells involved in MS attacks.
Siponimod (Mayzent): Specifically approved for secondary progressive MS, this drug helps reduce relapse frequency and delay disability.
Cladribine (Mavenclad): An immune reconstitution therapy taken in short courses over two years.
Natalizumab (Tysabri): A monoclonal antibody that blocks immune cells from entering the brain and spinal cord.
Ocrelizumab (Ocrevus): One of the few DMTs approved for both relapsing and primary progressive MS. It targets B cells that are believed to contribute to nerve damage.
Alemtuzumab (Lemtrada): A strong immunosuppressive treatment typically reserved for people who haven’t responded well to other therapies.
Each DMT carries its own potential benefits and risks, and treatment selection depends on factors like disease severity, lifestyle, and tolerance to side effects. Neurologists often monitor patients regularly through MRI scans and blood tests to evaluate the effectiveness and safety of the chosen DMT.
4. Symptom Management Medications
In addition to modifying the course of MS, many patients require treatments to manage day-to-day symptoms, such as:
Muscle relaxants (e.g., Baclofen, Tizanidine) for spasticity and stiffness
Antidepressants to combat mood swings and depression associated with chronic illness
Bladder and bowel control medications
Pain relievers (both prescription and over-the-counter) for nerve and musculoskeletal pain
Fatigue-reducing drugs, such as Amantadine or Modafinil
Cognitive enhancers, like Donepezil, for memory and concentration issues
5. Physical and Occupational Therapy
Rehabilitation is a critical part of MS treatment. Physical therapists help patients maintain strength, flexibility, balance, and mobility. Occupational therapists work with patients to improve daily function and independence through adaptive tools and strategies.
These therapies can help patients:
Improve walking ability
Reduce muscle stiffness
Adapt to physical limitations
Prevent falls and injuries
Regular rehabilitation also helps counteract the effects of inactivity, especially in progressive stages of MS.
6. Speech and Cognitive Therapy
Patients experiencing speech difficulties or cognitive decline benefit from specialized therapies. Speech-language pathologists assist with communication challenges, while cognitive therapists focus on memory, attention, and problem-solving skills.
7. Psychological Support and Mental Health Care
Living with MS can take a toll on mental health. Many individuals experience:
Depression
Anxiety
Emotional lability (sudden mood changes)
Psychological counseling, support groups, and medications like SSRIs or SNRIs can significantly improve a patient’s emotional resilience and outlook on life.
8. Lifestyle Modifications and Wellness Strategies
Complementing conventional treatment with healthy lifestyle changes can improve MS outcomes:
A balanced anti-inflammatory diet (rich in omega-3s, antioxidants, and whole foods)
Regular low-impact exercise, like swimming, yoga, or walking
Stress-reduction techniques such as meditation, mindfulness, or deep breathing
Adequate sleep and rest to support nervous system recovery
Smoking cessation, as tobacco use worsens MS symptoms and progression
The management of Multiple Sclerosis requires a multidisciplinary approach. Neurologists, rehabilitation specialists, psychologists, and primary care providers work together to customize a treatment plan that addresses the individual’s specific MS type, symptoms, and goals.
Although MS is a lifelong condition, modern medicine offers a growing arsenal of tools to help patients maintain independence and live fulfilling lives. With ongoing research and advancements—including emerging therapies like medical marijuana for multiple sclerosis—the future of MS treatment continues to evolve with hope and promise.
How Cannabis Can Help MS Patients
Medical cannabis is gaining increasing recognition as a supportive therapy for people living with Multiple Sclerosis (MS). While it is not a cure, numerous studies and patient experiences suggest that cannabis can offer significant relief from many of the debilitating symptoms associated with MS, such as muscle spasms, chronic pain, fatigue, and sleep disturbances.
As conventional treatments focus primarily on modifying disease progression or reducing inflammation, medical marijuana (Cannabis sativa) offers a more holistic approach by improving day-to-day comfort and quality of life.
The Science Behind Cannabis and MS Relief
Cannabis contains over 100 active compounds known as cannabinoids, the most notable being tetrahydrocannabinol (THC) and cannabidiol (CBD). These cannabinoids interact with the endocannabinoid system (ECS)—a complex network of receptors throughout the brain and body that plays a critical role in regulating pain, immune function, sleep, and mood.
For people with MS, cannabis can help rebalance the ECS, offering therapeutic benefits in multiple ways:
THC: Known for its psychoactive effects, THC can reduce pain perception, ease muscle spasms, and stimulate appetite.
CBD: A non-psychoactive cannabinoid that has anti-inflammatory, neuroprotective, and anti-anxiety properties.
Together, THC and CBD may help modulate immune responses, calm overactive nerves, and offer much-needed relaxation—both physically and mentally.
Related: CBD vs. THC: How Do They Differ?
Key Benefits of Medical Cannabis for MS Patients
Relief from Muscle Spasticity and Spasms
Muscle stiffness and involuntary spasms are among the most painful and disruptive symptoms of MS. Research shows that cannabis-based medications, such as nabiximols (Sativex)—a THC:CBD mouth spray—can significantly reduce muscle tone and spasticity, especially in patients who are resistant to traditional treatments.
2. Chronic Pain Management
Many MS patients suffer from neuropathic pain, which results from nerve damage and is often difficult to treat. Cannabinoids work by interfering with pain signals in the brain and spinal cord, helping to reduce pain intensity and improve comfort without the addictive risks of opioids.
3. Improved Sleep Quality
Fatigue and sleep disturbances are common in MS. Cannabis, particularly strains high in indica and CBD, can promote relaxation and deeper sleep cycles. Better sleep helps the body heal, supports mental clarity, and improves overall energy levels.
4. Bladder Control Support
MS can impair nerve signals that control the bladder, leading to incontinence, urgency, and frequent urination. Some users report that medical cannabis helps them regain better control over bladder function, though more clinical research is needed in this area.
5. Cognitive and Mood Stabilization
Cannabis has been shown to help regulate mood disorders, including anxiety and depression—two common co-occurring conditions among MS patients. CBD in particular may help ease stress, reduce irritability, and promote emotional balance.
Some early research even suggests that cannabinoids might offer neuroprotective benefits, helping to prevent long-term brain damage and cognitive decline, though this is still under active investigation.
6. Reduction in Inflammation
As an autoimmune condition, MS involves chronic inflammation of the nervous system. Cannabinoids, especially CBD, are believed to possess strong anti-inflammatory properties that may help calm immune system overactivity and prevent further damage to nerves.
7. Appetite Stimulation and Digestive Support
Cannabis is well known for stimulating appetite ("the munchies"). For MS patients experiencing weight loss or poor appetite—especially those on medications that cause nausea—medical marijuana can encourage healthy eating habits and reduce digestive discomfort.
Methods of Consuming Medical Marijuana
Patients have various consumption methods available depending on their needs, preferences, and medical advice:
Dried Cannabis Flower: Can be smoked or vaporized for fast relief.
Oils and Tinctures: Placed under the tongue or added to food/drinks; provide long-lasting effects.
Capsules and Pills: Offer precise dosing for consistent symptom management.
Edibles: Gummies, chocolates, or baked goods; effects take longer to onset but last longer.
Topicals: Creams or balms applied to the skin to reduce localized pain and inflammation.
Vape Pens: Allow quick absorption and are often preferred for sudden symptoms like muscle spasms.
Each method has its pros and cons, and finding the right strain, dosage, and delivery method often requires some trial and error under medical supervision.
It's crucial to consult a medical professional to determine the best delivery method and dosage based on individual symptoms.
Side Effects of Medical Marijuana
Like any medication, medical marijuana may cause side effects, especially when consumed in high doses or without proper guidance. Common side effects include:
Dry mouth and eyes
Dizziness or drowsiness
Increased heart rate
Mood changes or anxiety
Short-term memory impairment
Hunger and weight gain
Importantly, some strains may cause psychoactive effects due to THC. For MS patients new to cannabis, starting with low doses of CBD-dominant products is usually recommended to avoid unwanted reactions.
Additionally, cannabis may interact with other medications, such as sedatives, antidepressants, or blood thinners, so it's essential to consult with a healthcare provider before starting cannabis therapy.
One key advantage is that cannabis may provide relief with fewer side effects than some conventional MS medications.
Drug Interactions: Is It Safe to Combine Cannabis with Other MS Medications?
Medical marijuana may interact with other drugs, especially those affecting the nervous system. However, it's generally considered safe when prescribed alongside:
Dronabinol
Nabilone
Nabiximols
These synthetic cannabinoid medications are already approved for treating MS-related symptoms in various countries. Always consult a qualified healthcare provider before combining cannabis with prescription drugs.
Related: Can You Mix Wegovy and Cannabis Together?
How to Get a Virginia Medical Marijuana Card for MS
If you live in Virginia and suffer from Multiple Sclerosis, you can legally access medical marijuana through a streamlined process with CannabisMD TeleMed. Here's how:
Step-by-Step Process:
Book an Online Appointment
Schedule a virtual consultation with a state-licensed marijuana doctor.Get Evaluated
The doctor will review your medical history and MS symptoms to determine eligibility.Receive Certification
If approved, you’ll receive a medical marijuana certificate valid for use at licensed dispensaries.Apply for a Medical Marijuana Card
Use your certification to apply for and obtain your official medical cannabis card in Virginia.Purchase at Dispensaries
Visit a local medical marijuana dispensary and choose products that best suit your treatment needs.
CannabisMD TeleMed offers a 99% approval rate and a money-back guarantee if you're not certified. You don’t even need to leave home—everything is handled virtually.
Related: Medical Marijuana Certification Appointment for New Patients
Final Thoughts: Medical Marijuana as a Complementary Treatment for MS
While not a cure, medical cannabis for MS provides a natural and effective option for symptom management. Whether you're struggling with muscle spasms, fatigue, or pain, incorporating cannabis into your treatment plan could significantly improve your daily life.
If you’re ready to explore medical marijuana treatment for Multiple Sclerosis in Virginia, start with a trusted provider like CannabisMD TeleMed. With expert physicians, fast online appointments, and personalized care, relief is just a click away.
FAQs
1. Can medical marijuana cure Multiple Sclerosis?
No, medical marijuana cannot cure MS. However, it can help manage symptoms such as muscle spasms, pain, fatigue, and sleep disturbances. It’s used as a complementary therapy alongside conventional treatments.
2. What are the best cannabis strains or products for MS symptoms?
Strains or products high in CBD and moderate THC are often recommended. Popular options include CBD oils, edibles, vape pens, and capsules. Always consult with a licensed medical provider to determine what works best for your needs.
3. Are there side effects of using medical marijuana for MS?
Yes, common side effects include dry mouth, dizziness, increased appetite, red eyes, and drowsiness. Most side effects are mild and manageable but should be discussed with your doctor.
4. How do I get a medical marijuana card in Virginia for MS?
You can get certified online through CannabisMD TeleMed by booking a virtual appointment with a licensed provider. After approval, you'll receive a certificate to purchase from licensed dispensaries.
5. Is medical marijuana legal in Virginia?
Yes, medical marijuana is legal in Virginia with proper certification from a registered healthcare provider. Patients must carry a valid medical marijuana card to purchase cannabis legally.
References
Christelle M Andre, J.-F. H. (2016, February 4). https://www.frontiersin.org/articles/10.3389/fpls.2016.00019/full. Retrieved from www.frontiersin.org: https://www.frontiersin.org/articles/10.3389/fpls.2016.00019/full
Heidi Moawad, M. (2021, August 12). Understanding Symptoms of Multiple Sclerosis (MS). https://www.healthline.com/ , p. 1.
https://www.cabi.org/isc/datasheet/14497. (n.d.).
Lillian Cruz-Orengo, B. P.-R. (2014, May 8). https://pubmed.ncbi.nlm.nih.gov/24812668/#&gid=article-figures&pid=figure-1-uid-0. Retrieved June 12, 2014, from https://pubmed.ncbi.nlm.nih.gov/24812668/: https://www.jci.org/articles/view/73408
Michelle Cameron, M. P. (2020, June 18). https://nmsscdn.azureedge.net/NationalMSSociety/media/MSNationalFiles/Professionals/Cannabis-and-Multiple-Sclerosis.pdf. Retrieved 2017, from https://nmsscdn.azureedge.net/.